Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Avoid excessive heat, contamination, and improper handling during storage and evaluation.
Avoid extreme temperatures
Technologies enabling gene editing or cell-based therapies to enhance performancesuch as follistatin AAV1-FS344, which has documented muscle growth effects in nonhuman primatesfall under this classification
From January 1, 2025, through December 31, 2027, a medical device is eligible for separate payment if CMS determines it meets all of the following requirements: * * * * * (c) * * * (1) For a qualifying drug or biological as defined in paragraph (a) of this section, the amount of payment is the amount determined under section 1847A of the Act for the drug or biological that exceeds the portion of the otherwise applicable Medicare OPD fee schedule amount, subject to paragraph (c)(3) of this section
US$ 25.83
US$ 29.42
US$ 27.19
